Olema Pharmaceuticals (OLMA) Non-cash Items (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Non-cash Items data on file, last reported at $91.9 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $91.9 million, up 6861.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.9 million (up 6861.44% YoY), and the FY2025 annual result was $235.7 million, up 3034.19% from the prior year.
• Non-cash Items slipped to $91.9 million in Q1 2026 per OLMA's latest filing, from $235.7 million in the prior quarter.
• Over five years, Non-cash Items peaked at $235.7 million in Q4 2025 and troughed at $262000.0 in Q4 2022.
• A 5-year average of $39.1 million and a median of $31.6 million in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items sank 99.51% in 2022, then surged 23468.32% in 2023.
• A 5-year view of Non-cash Items shows it stood at $262000.0 in 2022, then surged by 23468.32% to $61.7 million in 2023, then tumbled by 87.82% to $7.5 million in 2024, then soared by 3034.19% to $235.7 million in 2025, then slumped by 61.01% to $91.9 million in 2026.
• Business Quant data shows OLMA's Non-cash Items at $91.9 million in Q1 2026, $235.7 million in Q4 2025, and $52.0 million in Q3 2025.